CorMedix, Inc. (CRMD)
7.825
-0.14
(-1.70%)
USD |
NASDAQ |
Sep 11, 16:00
7.82
0.00 (0.00%)
After-Hours: 20:00
CorMedix Price : 7.825 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 8.04 | 8.06 | 7.82 | 7.825 | 820993.0 |
| Sep 10, 2026 | 8.11 | 8.12 | 7.92 | 7.96 | 857257.0 |
| Sep 09, 2026 | 8.18 | 8.33 | 8.08 | 8.13 | 928241.0 |
| Sep 08, 2026 | 8.28 | 8.37 | 8.11 | 8.18 | 1.101M |
| Sep 04, 2026 | 8.45 | 8.605 | 8.31 | 8.43 | 792913.0 |
| Sep 03, 2026 | 8.69 | 8.745 | 8.43 | 8.47 | 707673.0 |
| Sep 02, 2026 | 8.40 | 8.62 | 8.33 | 8.61 | 1.102M |
| Sep 01, 2026 | 8.25 | 8.49 | 8.18 | 8.38 | 880481.0 |
| Aug 31, 2026 | 8.26 | 8.29 | 8.06 | 8.26 | 980535.0 |
| Aug 28, 2026 | 8.28 | 8.395 | 8.185 | 8.30 | 780215.0 |
| Aug 27, 2026 | 8.49 | 8.49 | 8.280 | 8.31 | 707587.0 |
| Aug 26, 2026 | 8.60 | 8.605 | 8.37 | 8.39 | 865513.0 |
| Aug 25, 2026 | 8.35 | 8.575 | 8.28 | 8.56 | 1.236M |
| Aug 24, 2026 | 8.28 | 8.495 | 8.18 | 8.28 | 1.012M |
| Aug 21, 2026 | 8.29 | 8.41 | 8.155 | 8.20 | 1.497M |
| Aug 20, 2026 | 8.49 | 8.545 | 8.19 | 8.23 | 1.006M |
| Aug 19, 2026 | 8.30 | 8.53 | 8.11 | 8.52 | 1.467M |
| Aug 18, 2026 | 7.71 | 8.27 | 7.71 | 8.17 | 2.033M |
| Aug 17, 2026 | 7.55 | 8.11 | 7.480 | 7.67 | 2.174M |
| Aug 14, 2026 | 8.05 | 8.198 | 7.46 | 7.54 | 2.701M |
| Aug 13, 2026 | 8.39 | 8.98 | 7.76 | 8.14 | 6.070M |
| Aug 12, 2026 | 7.30 | 7.31 | 7.10 | 7.10 | 1.353M |
| Aug 11, 2026 | 7.60 | 7.62 | 7.25 | 7.30 | 1.182M |
| Aug 10, 2026 | 7.40 | 7.55 | 7.31 | 7.53 | 842650.0 |
| Aug 07, 2026 | 7.58 | 7.585 | 7.395 | 7.44 | 740966.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Innoviva, Inc. | 20.66 |
| Zevra Therapeutics, Inc. | 12.01 |
| Filana Therapeutics, Inc. | 0.7726 |
| Eloxx Pharmaceuticals, Inc. | 15.75 |
| Cannabis Global, Inc. | 0.0000 |
Price Related Metrics
| PE Ratio | 3.718 |
| PS Ratio | 1.547 |
| PEG Ratio | 0.0204 |
| Price to Book Value | 1.319 |
| Price to Free Cash Flow | 2.860 |
| Earnings Yield | 26.90% |
| Market Cap | 607.74M |
| PEGY Ratio | 0.0204 |
| Operating PE Ratio | 3.295 |
| Normalized PE Ratio | 3.554 |